Bristol-Myers Squibb Co. (BMY) — Analysis Summary
Bristol-Myers Squibb Co. (BMY) has a market cap of $116.77B with year-over-year revenue growth of -0.2%. Net margin stands at 14.6%. The stock trades at a P/E ratio of 16.1.
Key Takeaways
- Revenue changed -0.2% year-over-year
- Net margin of 14.6%
- P/E ratio of 16.1
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, BMY posted revenue growth of -0.2% and trades at a P/E of 16.1.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.